AU5903600A - A novel vascular endothelial growth factor family member and uses thereof - Google Patents

A novel vascular endothelial growth factor family member and uses thereof

Info

Publication number
AU5903600A
AU5903600A AU59036/00A AU5903600A AU5903600A AU 5903600 A AU5903600 A AU 5903600A AU 59036/00 A AU59036/00 A AU 59036/00A AU 5903600 A AU5903600 A AU 5903600A AU 5903600 A AU5903600 A AU 5903600A
Authority
AU
Australia
Prior art keywords
growth factor
vascular endothelial
family member
endothelial growth
factor family
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU59036/00A
Inventor
David P Gearing
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Millennium Pharmaceuticals Inc
Original Assignee
Millennium Pharmaceuticals Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Millennium Pharmaceuticals Inc filed Critical Millennium Pharmaceuticals Inc
Publication of AU5903600A publication Critical patent/AU5903600A/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52—Cytokines; Lymphokines; Interferons
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6872—Intracellular protein regulatory factors and their receptors, e.g. including ion channels
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/475—Assays involving growth factors

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Urology & Nephrology (AREA)
  • Biomedical Technology (AREA)
  • Immunology (AREA)
  • General Health & Medical Sciences (AREA)
  • Hematology (AREA)
  • Medicinal Chemistry (AREA)
  • Biochemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Organic Chemistry (AREA)
  • Cell Biology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Food Science & Technology (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Microbiology (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
AU59036/00A 1999-06-30 2000-06-29 A novel vascular endothelial growth factor family member and uses thereof Abandoned AU5903600A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US34367199A 1999-06-30 1999-06-30
US09343671 1999-06-30
PCT/US2000/018085 WO2001000878A2 (en) 1999-06-30 2000-06-29 A novel vascular endothelial growth factor family member and uses thereof

Publications (1)

Publication Number Publication Date
AU5903600A true AU5903600A (en) 2001-01-31

Family

ID=23347104

Family Applications (1)

Application Number Title Priority Date Filing Date
AU59036/00A Abandoned AU5903600A (en) 1999-06-30 2000-06-29 A novel vascular endothelial growth factor family member and uses thereof

Country Status (2)

Country Link
AU (1) AU5903600A (en)
WO (1) WO2001000878A2 (en)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6630142B2 (en) 1999-05-03 2003-10-07 Zymogenetics, Inc. Method of treating fibroproliferative disorders
US6468543B1 (en) 1999-05-03 2002-10-22 Zymogenetics, Inc. Methods for promoting growth of bone using ZVEGF4
WO2001025437A2 (en) * 1999-10-07 2001-04-12 Curagen Corporation Growth factor polypeptides and nucleic acids encoding same
AU2001272902A1 (en) * 2000-05-19 2001-12-03 Eli Lilly And Company Treating musculoskeletal disorders using lp85 and analogs thereof

Also Published As

Publication number Publication date
WO2001000878A2 (en) 2001-01-04
WO2001000878A9 (en) 2002-07-25

Similar Documents

Publication Publication Date Title
AU2002252631A1 (en) Vascular endothelial growth factor 2
AU5023300A (en) Vascular endothelial growth factor variants
AU2002256172A1 (en) Vascular endothelial growth factor 2
AU7373700A (en) Vascular closure
AU5439998A (en) Vascular endothelial growth factor
EP1313512A4 (en) Vascular endothelial growth factor 2
AU1454200A (en) Compositions and articles made therefrom
AU2583399A (en) Variants of the angiogenic factor vascular endothelial cell growth factor: vegf
AU2001281758A1 (en) Biocompatible materials
EP1062319A4 (en) Vascular endothelial growth factor 2
AU2001288720A1 (en) Implantable article
AU2002227441A1 (en) Biocompatible adhesives
AU4481500A (en) Variable strength stent
AU3924300A (en) Fibroblast growth factor-20
AU1628101A (en) Jaffa, a novel fibroblast growth factor family member and uses therefor
AU1890300A (en) Novel interferon-alpha
AU1890599A (en) Novel microorganism and use thereof
HUP0200827A3 (en) Vascular endothelial cell growth factor variants and uses thereof
AU4051700A (en) Angular vascular stent
AU5026100A (en) Vascular endothelial growth factor dimers
AU2002313770A1 (en) Vascular endothelial growth factor 2
AU5903600A (en) A novel vascular endothelial growth factor family member and uses thereof
AU2466800A (en) Spinning top and actuating member therefor
AU2536600A (en) Biocompatible material with a novel functionality
AU5979300A (en) Angiopoietin-6 and uses thereof

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase